Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 225 of 2873 entries
View as:

Patient Perceptions Around Quality of Care Through Telemedicine in Neuro-Oncology

Phase: N/A Priority: Normal
NCT ID: NCT04988009 Org: User:
Start: 08/20/20 End: 12/31/26 Due: 12/31/27

Nivolumab and ADI-PEG 20 Before Surgery for the Treatment of Resectable Liver Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04965714 Org: User:
Start: 04/13/22 End: 02/10/23 Due: 02/10/24

Atorvastatin in Treating Patients With Stage IIb-III Triple Negative Breast Cancer Who Did Not Achieve a Pathologic Complete Response After Receiving Neoadjuvant Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT03872388 Org: User:
Start: 09/23/19 End: 10/19/23 Due: 10/19/24

Quality of Life Study for Prostate Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT00561444 Org: User:
Start: 11/14/07 End: 11/30/20 Due: 11/30/21

Tranexamic Acid in Reducing Blood Loss in Patients With Pelvic Tumors Undergoing Hemipelvectomy Surgery

Phase: N/A Priority: Normal
NCT ID: NCT03128866 Org: User:
Start: 05/19/17 End: 05/31/26 Due: 05/31/27

PhI/II Study of Amivantamab and Tepotinib Combo in MET-altered Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06083857 Org: User:
Start: 06/18/24 End: 12/31/27 Due: 12/31/28

Vorinostat and Temsirolimus With or Without Radiation Therapy in Treating Younger Patients With Newly Diagnosed or Progressive Diffuse Intrinsic Pontine Glioma

Phase: N/A Priority: Normal
NCT ID: NCT02420613 Org: User:
Start: 10/05/15 End: 03/28/25 Due: 03/28/26

Pomalidomide for Myelofibrosis Patients

Phase: N/A Priority: Normal
NCT ID: NCT00946270 Org: User:
Start: 07/22/09 End: 05/22/18 Due: 05/22/19

Nuclear Imaging of Human CSF Flow Using Ga-67 Citrate and In-111 DTPA

Phase: N/A Priority: Normal
NCT ID: NCT00477503 Org: User:
Start: 05/31/07 End: 07/31/09 Due: 07/31/10

A Phase I Study of Adagrasib and Durvalumab for Treatment of Advanced Non-small Cell Lung Cancers and Gastro-intestinal Cancers Harboring KRAS G12C Mutations

Phase: N/A Priority: Normal
NCT ID: NCT05848843 Org: User:
Start: 04/25/23 End: 01/16/24 Due: 01/16/25

Older Men's Decision Making About Active Surveillance for Prostate Cancer - Aim 3: Decision Aid Efficacy Testing

Phase: N/A Priority: Normal
NCT ID: NCT06785441 Org: User:
Start: 05/25/23 End: 02/02/30 Due: 02/02/31

Haloperidol and Lorazepam in Controlling Symptoms of Persistent Agitated Delirium in Patients With Advanced Cancer Undergoing Palliative Care

Phase: N/A Priority: Normal
NCT ID: NCT03743649 Org: User:
Start: 07/17/19 End: 12/31/26 Due: 12/31/27

Evaluation of Single Session Stereotactic Body Radiotherapy

Phase: N/A Priority: Normal
NCT ID: NCT00492817 Org: User:
Start: 10/13/05 End: 11/27/24 Due: 11/27/25

High-Flow Oxygen in Reducing Shortness of Breath Caused by Exercise in Patients With Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02357134 Org: User:
Start: 03/17/15 End: 05/31/23 Due: 05/31/24

Combined Levothyroxine/Liothyronine Supplementation in Hypothyroid Patients With Brain Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00488644 Org: User:
Start: 02/28/06 End: 03/31/10 Due: 03/31/11

Daratumumab, Bortezomib, and Dexamethasone Followed by Daratumumab, Ixazomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT03763162 Org: User:
Start: 01/17/19 End: 04/30/25 Due: 04/30/26

Technology-Enhanced Palliative Care for Advanced Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT04989556 Org: User:
Start: 08/20/20 End: 05/07/26 Due: 05/07/27

Intraoperative Acupoint Stimulation to Prevent Post-Operative Nausea and Vomiting (PONV)

Phase: N/A Priority: Normal
NCT ID: NCT02473042 Org: User:
Start: 02/29/16 End: 11/26/24 Due: 11/26/25

Local Consolidative Therapy and Durvalumab for Oligoprogressive and Polyprogressive Stage III NSCLC After Chemoradiation and Anti-PD-L1 Therapy

Phase: N/A Priority: Normal
NCT ID: NCT04892953 Org: User:
Start: 07/07/21 End: 09/30/26 Due: 09/30/27

Risk Reducing Salpingectomy With Delayed Oophorectomy as an Alternative to Risk- Reducing Salpingo-oophorectomy in High Risk-Women to Assess the Safety of Prevention - US Cohort Study

Phase: N/A Priority: Normal
NCT ID: NCT05287451 Org: User:
Start: 05/10/22 End: 12/26/26 Due: 12/26/27

SGN-35 in CD30-positive Lymphoproliferative Disorders (ALCL), Mycosis Fungoides (MF), and Extensive Lymphomatoid Papulosis (LyP)

Phase: N/A Priority: Normal
NCT ID: NCT01352520 Org: User:
Start: 06/30/11 End: 01/31/26 Due: 01/31/27

ASTX727 and Dasatinib for the Treatment of Newly Diagnosed Philadelphia Chromosome or BCR-ABL Positive Chronic Myeloid Leukemia in Chronic Phase

Phase: N/A Priority: Normal
NCT ID: NCT05007873 Org: User:
Start: 10/21/21 End: 10/30/26 Due: 10/30/27

Thoracic Epidural Analgesia or Four-Quadrant Transversus Abdominus Plane Block in Reducing Pain in Patients Undergoing Liver Surgery

Phase: N/A Priority: Normal
NCT ID: NCT03214510 Org: User:
Start: 10/04/17 End: 07/31/26 Due: 07/31/27

Prediction of Recurrence Among Low Risk Endometrial Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT04604613 Org: User:
Start: 11/08/12 End: 12/31/26 Due: 12/31/27

Ipilimumab, Ibrutinib, and Nivolumab for the Treatment of Chronic Lymphocytic Leukemia and Richter Transformation

Phase: N/A Priority: Normal
NCT ID: NCT04781855 Org: User:
Start: 07/14/22 End: 02/21/25 Due: 02/21/26